Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02969707 · ClinicalTrials.gov registry record · NA
Use of Repetitive Transcranial Magnetic Stimulation to Augment Hypnotic Analgesia
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
NCT02969707: Completed NA study, sponsored by Stanford University.
NCT02969707 is a NA study that has completed, run by Stanford University. The registered enrollment target is 101 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02969707, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
Study Summary
The investigators plan to use functional neuroimaging (fMRI) to understand the brain systems affected when hypnosis and hypnotic analgesia are augmented with repetitive transcranial magnetic stimulation (rTMS), a form of non-invasive brain stimulation to 100 people with fibromyalgia, a chronic pain condition. The investigators will measure the effect of rTMS-augmentation on the brain networks underlying hypnotizability, as well as the effect of rTMS-augmentation on hypnotic analgesia networks. The investigators hope to demonstrate that a combination of these psychological and neuromodulatory treatments will be more effective than hypnosis alone, thereby enhancing the depth of hypnosis, range of hypnosis and the efficacy of hypnotic analgesia and hopefully creating a new treatment modality for individuals suffering from pain syndromes such as fibromyalgia pain.
Interventions
- BEHAVIORAL Hypnosis
- DEVICE MagPro TMS system (MagVenture, Denmark)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2017-04-24 |
| Est. Completion | 2019-12-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02969707
The ClinicalTrials.gov registry entry for NCT02969707 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hypnosis is the first listed.
NCT02969707 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02969707 about?
NCT02969707 is a clinical study titled "Use of Repetitive Transcranial Magnetic Stimulation to Augment Hypnotic Analgesia". The investigators plan to use functional neuroimaging (fMRI) to understand the brain systems affected when hypnosis and hypnotic analgesia are augmented with repetitive transcranial magnetic stimulation (rTMS), a form of non-invasive brain stimulation to 100 people with fibromyalgia, a chronic pain ...
What is the current status of trial NCT02969707?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2017-04-24. Estimated completion is 2019-12-21.
What interventions are being tested in trial NCT02969707?
The interventions under investigation include: Hypnosis (BEHAVIORAL), MagPro TMS system (MagVenture, Denmark) (DEVICE).
Who is sponsoring clinical trial NCT02969707?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.